The Eagles defeated J.P. Taravella in competition at the Coral Springs Aquatic Complex on September 17. The team is preparing ...
MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
During this industry reshuffling phase, characterized by the strong getting stronger and the weak being eliminated, FAW Toyota has charted a path of growth against the trend: in the first eight months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback